V

Vistin Pharma ASA
OSE:VISTN

Watchlist Manager
Vistin Pharma ASA
OSE:VISTN
Watchlist
Price: 24.2 NOK -2.02% Market Closed
Market Cap: 1.1B NOK
Have any thoughts about
Vistin Pharma ASA?
Write Note

Wall Street
Price Targets

VISTN Price Targets Summary
Vistin Pharma ASA

There are no price targets for VISTN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Vistin Pharma ASA Competitors:
Price Targets
603566
Pulike Biological Engineering Inc
13% Upside
605116
Aurisco Pharmaceutical Co Ltd
43% Upside
MNMD
Mind Medicine (MindMed) Inc
219% Upside
NWRN
Newron Pharmaceuticals SpA
85% Upside
APPH
Apontis Pharma AG
83% Upside
AVDL
Avadel Pharmaceuticals PLC
116% Upside
000538
Yunnan Baiyao Group Co Ltd
12% Upside
INVA
Innoviva Inc
5% Downside

Revenue
Forecast

Revenue Estimate
Vistin Pharma ASA

For the last 7 years the compound annual growth rate for Vistin Pharma ASA's revenue is 14%. The projected CAGR for the next 6 years is -14%.

14%
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Vistin Pharma ASA

For the last 7 years the compound annual growth rate for Vistin Pharma ASA's operating income is 18%. The projected CAGR for the next 6 years is -20%.

18%
Past Growth
-20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Vistin Pharma ASA

For the last 7 years the compound annual growth rate for Vistin Pharma ASA's net income is 20%. The projected CAGR for the next 6 years is -7%.

20%
Past Growth
-7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VISTN's stock price target?
Not Available

VISTN doesn't have any price targets made by Wall Street professionals.

What is Vistin Pharma ASA's Revenue forecast?
Projected CAGR
-14%

For the last 7 years the compound annual growth rate for Vistin Pharma ASA's revenue is 14%. The projected CAGR for the next 6 years is -14%.

What is Vistin Pharma ASA's Operating Income forecast?
Projected CAGR
-20%

For the last 7 years the compound annual growth rate for Vistin Pharma ASA's operating income is 18%. The projected CAGR for the next 6 years is -20%.

What is Vistin Pharma ASA's Net Income forecast?
Projected CAGR
-7%

For the last 7 years the compound annual growth rate for Vistin Pharma ASA's net income is 20%. The projected CAGR for the next 6 years is -7%.

Back to Top